QT
SAGE

Quantbot Technologies’s Sage Therapeutics SAGE Stock Holding History

Quantbot Technologies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-416
Closed -$13K – 2077
2022
Q1 		$13K Buy
+416
New +$15.6K ﹤0.01% 1432
2021
Q2 		– Sell
-587
Closed -$43K – 1812
2021
Q1 		$43K Buy
+587
New +$48.1K ﹤0.01% 1043
2020
Q2 		– Sell
-533
Closed -$15K – 1403
2020
Q1 		$15K Buy
+533
New +$30.9K 0.01% 637
2019
Q4 		– Sell
-771
Closed -$108K – 1537
2019
Q3 		$108K Buy
+771
New +$129K 0.01% 821
2018
Q4 		– Sell
-191
Closed -$26K – 1359
2018
Q3 		$26K Buy
+191
New +$29.5K ﹤0.01% 1120
2017
Q3 		– Sell
-1,102
Closed -$87K – 1400
2017
Q2 		$87K Sell
1,102
-246
-18% -$17.8K 0.01% 828
2017
Q1 		$95K Sell
1,348
-740
-35% -$43.3K 0.01% 800
2016
Q4 		$106K Buy
+2,088
New +$98.4K 0.01% 699
2016
Q3 		– Sell
-2,895
Closed -$87K – 1294
2016
Q2 		$87K Sell
2,895
-745
-20% -$24.8K 0.01% 752
2016
Q1 		$116K Buy
3,640
+1,726
+90% +$60.8K 0.02% 686
2015
Q4 		$111K Buy
1,914
+624
+48% +$30.9K 0.02% 620
2015
Q3 		$54K Buy
1,290
+1,282
+16,025% +$79K 0.01% 899
2015
Q2 		$0 Sell
8
-1,191
-99% -$76.6K ﹤0.01% 1332
2015
Q1 		$60K Buy
+1,199
New +$51.5K 0.01% 739

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Quantbot Technologies's SAGE Position: Q2 2022 in Review

Quantbot Technologies sold out of Sage Therapeutics (SAGE) in Q2 2022, closing a stake of 416 shares — an estimated $13K sold.

Quantbot Technologies first reported a position in SAGE in Q1 2015 and held it in 14 quarters. The position peaked at $116K in Q1 2016. 210 funds tracked by Wall St. Rank hold SAGE as of Q2 2022.

  • Quantbot Technologies reported no remaining Sage Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 416 Sage Therapeutics shares in Q2 2022, an estimated $13K.
  • Quantbot Technologies first reported a position in Sage Therapeutics in Q1 2015 and held it in 14 quarters.
  • Quantbot Technologies's Sage Therapeutics position peaked at $116K in Q1 2016.
  • 210 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.